The generated CTLs efficiently lysed cells of all glioma cell lines, whereas only marginal lysis was observed when the SOX2-negative melanoma cell line 93.04A12.1 expressing HLA-A2 was used as a control (Figure 5B and C). This evidence concerns the gene SOX2 and central nervous system cancer.